Saturday 17 October 2026
Export USPH’s income statement to Excel — free account
U.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.47%, EPS fell 56.9%, free cash flow fell 8.24% and total debt rose 41.8%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
85.71
0.27
−0.31%
Follow USPH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
8.84% | 8.19% | 5.30% | 4.34% | |
Piotroski F-Score |
5 | 7 | 6 | 6 | |
| 3.93% | 3.34% | 2.12% | 1.70% | ||
ROIC |
8.95% | 9.12% | 7.83% | 7.48% | |
Return on Tangible Assets |
75.93% | 108.15% | 42.49% | 29.44% | |
Average Days of Receivables |
43.92 | 41.28 | 44.38 | 44.11 | |
Free Cash Flow per Share |
3.74 | 4.02 | 4.40 | 4.25 | |
Free Cash Flow |
56.90 | 60.99 | 66.68 | 64.07 | |
Capital Expenditures |
(12.63) | (14.07) | (16.86) | (18.98) | |
| Other line items | |||||
Cash ROIC |
8.28% | 9.17% | 9.64% | 9.29% | |
Accounts Receivable Turnover |
9.01 | 8.98 | 8.48 | 8.48 | |
Accounts Payable Turnover |
89.51 | 105.26 | 100.28 | 118.83 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
4.39 | 3.50 | 3.83 | 3.82 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.25) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.79% | 8.87% | 8.96% | 8.97% | |
Share Based Compensation of Revenue |
1.07% | 1.06% | 1.11% | 1.21% | |
Interest Coverage |
9.78 | 9.16 | 7.97 | 7.11 | |
Operating CF/Net income |
1.59 | 1.90 | 3.25 | 4.02 | |
Depreciation/Fixed assets |
0.70 | 0.64 | 0.59 | 0.56 | |
Capex/Depreciation |
(0.53) | (0.62) | (0.73) | (0.83) | |
Revenue per Share |
49.90 | 51.47 | 52.45 | 53.90 | |
Operating CF per Share |
4.57 | 4.95 | 5.51 | 5.51 | |
Capex per Share |
(0.83) | (0.93) | (1.11) | (1.26) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates